ALAYA.BIO Trademark

Trademark Overview


On Friday, July 26, 2024, a trademark application was filed for ALAYA.BIO with the United States Patent and Trademark Office. The USPTO has given the ALAYA.BIO trademark a serial number of 79408189. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, October 31, 2024. This trademark is owned by Alaya.bio. The ALAYA.BIO trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Biotechnology-derived products and preparations applied to the medical field; gene and cell therapy products and preparations; medical products, substances and preparations, namely, biotechnology-derived products and preparations for immunotherapy and cancer treatment, for autoimmune diseases, for genetic diseases, for diseases affecting the central nervous system.

Medical research; pharmacological research; research and development in the field of biotechnology; biotechnology advice; preparation of reports with respect to biotechnology; information about scientific research in the field of biochemistry and biotechnology; cell therapy and gene therapy research; in-vivo gene therapy and cell therapy research; immunotherapy research; oncology research; autoimmune disease research; genetic disease research; research into diseases affecting the central nervous system.
alaya.bio

General Information


Serial Number79408189
Word MarkALAYA.BIO
Filing DateFriday, July 26, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, October 31, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesBiotechnology-derived products and preparations applied to the medical field; gene and cell therapy products and preparations; medical products, substances and preparations, namely, biotechnology-derived products and preparations for immunotherapy and cancer treatment, for autoimmune diseases, for genetic diseases, for diseases affecting the central nervous system.
Pseudo MarkALAYA BIO
Goods and ServicesMedical research; pharmacological research; research and development in the field of biotechnology; biotechnology advice; preparation of reports with respect to biotechnology; information about scientific research in the field of biochemistry and biotechnology; cell therapy and gene therapy research; in-vivo gene therapy and cell therapy research; immunotherapy research; oncology research; autoimmune disease research; genetic disease research; research into diseases affecting the central nervous system.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 31, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 31, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAlaya.bio
Party Type10 - Original Applicant
Legal Entity Type34 - NOT AVAILABLE
AddressFR

Trademark Events


Event DateEvent Description
Thursday, October 31, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, November 1, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 1, 2024APPLICATION FILING RECEIPT MAILED